Philippe Nuss
Paris, 75012, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Beyond the At-Risk Mental State: Metastability and Hybrid States of Reality in Emerging Psychosis.
Journal: Schizophrenia bulletin
Published: February 09, 2026
Real-world effectiveness of antipsychotic polytherapy on rehospitalization in psychotic disorders: A French nationwide cohort analysis.
Journal: Comprehensive psychiatry
Published: January 28, 2026
Membrane Partition and Structural Reorganization Induced by Antipsychotics with Distinct Clinical Profiles.
Journal: ACS chemical neuroscience
Published: August 06, 2025
BDNF exerts an NRF2-dependent cytoprotective function via a receptor-independent pathway.
Journal: Cell reports
Published: March 04, 2025
Impact of Truncated Oxidized Phosphatidylcholines on Phospholipase A2 Activity in Mono- and Polyunsaturated Biomimetic Vesicles.
Journal: International journal of molecular sciences
Published: May 23, 2023
Real-world effectiveness of long-acting injectable antipsychotic treatments in a nationwide cohort of 12,373 patients with schizophrenia-spectrum disorders.
Journal: Molecular psychiatry
Published: January 05, 2023
How can we improve the care of patients with schizophrenia in the real-world? A population-based cohort study of 456,003 patients.
Journal: Molecular psychiatry
Published: January 03, 2023
Higher stress response and altered quality of life in schizophrenia patients with low membrane levels of docosahexaenoic acid.
Journal: Frontiers in psychiatry
Published: November 04, 2022
Fifty years of experience with loxapine for the rapid non-coercive tranquilization of acute behavioral disturbances in schizophrenia patients, and beyond.
Journal: Expert review of neurotherapeutics
Published: August 01, 2022
The impact of lipid polyunsaturation on the physical and mechanical properties of lipid membranes.
Journal: Biochimica et biophysica acta. Biomembranes
Published: May 27, 2022
Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus study.
Journal: BMC psychiatry
Published: February 24, 2022
Last Updated: 09/26/2026